The parent company of Hyland's, a long-time retailer of homeopathic treatments, had earlier announced it would stop making and distributing the products within the U.S.in October, following the FDA's recent advisory in September.
On January 25th, 2017, the FDA contacted Standard Homeopathic Company informing the company of these findings and ordering them to recall the products.
The maker of Hyland's teething tablets has issued a recall for any remaining packages at the urging of USA regulators, who say the medicine has inconsistent levels of a herb that can be poisonous. An FDA investigation found some tablets had much higher belladonna levels than listed on the products.
This is the second time in a decade that Hyland's has recalled teething tablets over belladonna concerns. This recall is to ensure that all products still on shelves are pulled.More news: First Teaser Trailer For Star Wars Episode VIII - The Last Jedi Released
In part because of how lightly regulated the supplement and alternative medicine industry is, however, it took years before the FDA took strong action against the Standard Homeopathic company.
"We are committed to maintaining and earning the trust consumers have placed in Standard Homeopathic Company", said CEO J.P. Borneman in a statement.
Standard Homeopathic Company is notifying its distributors and retailers by mail and is arranging for the return of all recalled products. The Agency has stated to the Company, "There is no known safe dose or toxic dose of belladonna in children because of the many factors that affect it".
Consumers with the products should throw them away.
You should also contact your physician or health care provider if you believe your child has experienced any issues related to taking this product.